Souhaitez-vous accéder aux communiqués récents ?

Continued operational excellence leading to acceleration of multiple timelines: ORKA-001, targeting IL-23p19, Phase 1 trial dosing complete, with data expected in 3Q 2025 ORKA-001 Phase 2a...

Revenue for the First Quarter Ended March 31, 2025 was $13.1 million Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules) Commercial Launch Off to a Strong Start, Initial Prescriptions...

Dublin, May 14, 2025 (GLOBE NEWSWIRE) -- The "Anti-Snoring Devices Market - Focused Insights 2025-2030" report has been added to ResearchAndMarkets.com's offering.The Anti-Snoring Devices Market...

Washington DC, May 14, 2025 (GLOBE NEWSWIRE) -- The National Academy of Social Insurance is excited to announce the addition of three new senior fellows, each of whom is a longtime leader in the...

CEDARVILLE, OHIO, May 14, 2025 (GLOBE NEWSWIRE) -- Obesity in the United States is a serious, yet common and costly, chronic disease. According to a study by the Center for Disease Control and...

WARSAW, Ind., May 14, 2025 (GLOBE NEWSWIRE) -- Lakeland Financial Corporation (Nasdaq Global Select/LKFN) and Lake City Bank announced today that Dan Starr and Mindy Creighton Truex have been...

BOWIE, Md., May 14, 2025 (GLOBE NEWSWIRE) -- Internationally acclaimed neurologist and epilepsy researcher Dr. Orrin Devinsky will be honored with the Lifetime Accelerator Award during the...

–FDA grants Priority Review of application, with PDUFA target action date of September 12, 2025– –ORLADEYO would be the first targeted oral prophylactic therapy for patients with HAE under the age of...

WASHINGTON, May 13, 2025 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute today awarded the Albert B. Sabin Gold Medal to pediatrician Katherine O’Brien, MD, MPH, for her research on the pneumococcal...

POCUS device and education bundle provides knowledge and experience to improve diagnostic accuracy, patient care, and clinical outcomes.